340B Drug Pricing Program
The AHA Feb. 28 filed a friend-of-the-court brief (https://www.aha.org/amicus-brief/2025-02-28-aha-others-file-amicus-brief-opposing-jj-340b-rebate-model) in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision…
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject Johnson & Johnson’s proposed 340B rebate model in a lawsuit brought by J&J to bar the…
AHA, others file amicus brief opposing J&J 340B rebate model.
AHA, others file amicus brief in Fourth Circuit in support of Maryland 340B contract pharmacy law.
AHA President and CEO Rick Pollack joined AHA’s Chad Golder, senior vice president and general counsel, Travis Robey, vice president of political affairs, and Shannon Wu, director of payment policy, for a discussion on the ever-shifting landscape of health care affairs on Capitol Hill.
Please ask your senators and representatives to prevent Medicaid disproportionate share hospital payment cuts from taking effect; extend enhanced low-volume adjustment and Medicare-dependent hospital programs that expand access to care in rural areas; and extend telehealth and hospital-at-home…
Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for patients in vulnerable communities.
AHA 340B Advocacy Alliance for January 7, 2025
AHA 340B Advocacy Alliance Bulletin for January 6, 2025.
AHA shares feedback in response to the Centers for Medicare & Medicaid Services’ information collection request (ICR) regarding the Medicare Transaction Facilitator (MTF) and the Medicare drug negotiation program.